Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Tarsus Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +8 vs. Q4 2021
- Shares held
- 13.2M
- +137.4K (+1.1%) vs. Q4 2021
- Total value
- $222.2M
- −$72.0M (−24.5%) vs. Q4 2021
- New holders
- 9
- 11 more added
- Sold out
- 1
- 19 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $2.98B |
| Q1 2026 | 253 | $3.17B |
| Q4 2025 | 246 | $3.61B |
| Q3 2025 | 220 | $2.67B |
| Q2 2025 | 205 | $1.87B |
| Q1 2025 | 195 | $2.26B |
| Q4 2024 | 195 | $2.23B |
| Q3 2024 | 162 | $1.43B |
| Q2 2024 | 148 | $1.09B |
| Q1 2024 | 157 | $1.43B |
| Q4 2023 | 116 | $652.0M |
| Q3 2023 | 105 | $529.4M |
| Q2 2023 | 92 | $387.3M |
| Q1 2023 | 74 | $252.1M |
| Q4 2022 | 69 | $301.0M |
| Q3 2022 | 75 | $350.8M |
| Q2 2022 | 73 | $291.7M |
| Q1 2022 | 51 | $222.2M |
| Q4 2021 | 43 | $294.2M |
| Q3 2021 | 44 | $277.4M |
| Q2 2021 | 44 | $378.5M |
| Q1 2021 | 41 | $410.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 2,987,331 | $50.2M | 3.46% | 00.0% | Unchanged |
| RTW Investments, LP | 2,013,601 | $33.9M | 0.70% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,417,157 | $23.8M | 2.03% | +1,417,157 | New |
| Cormorant Asset Management, LP | 1,375,982 | $23.1M | 1.78% | −27,349−1.9% | Reduced |
| Perceptive Advisors LLC | 1,296,416 | $21.8M | 0.45% | 00.0% | Unchanged |
| TimesSquare Capital Management, LLC | 659,600 | $11.1M | 0.12% | −1,200−0.2% | Reduced |
| Cowen and Company, LLC | 534,524 | $8.99M | 0.91% | +20,235+3.9% | Added |
| Vanguard Group Inc | 458,816 | $7.72M | 0.00% | −374−0.1% | Reduced |
| BlackRock Inc. | 439,958 | $7.40M | 0.00% | −9,000−2.0% | Reduced |
| Jefferies Group LLC | 402,758 | $6.77M | 0.16% | −20,235−4.8% | Reduced |
| Tang Capital Management LLC | 300,000 | $5.05M | 1.02% | +300,000 | New |
| Sands Capital Ventures, LLC | 260,000 | $4.37M | 0.91% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 242,451 | $4.08M | 0.01% | 00.0% | Unchanged |
| State Street Corp | 132,883 | $2.23M | 0.00% | +3,141+2.4% | Added |
| Geode Capital Management, LLC | 130,758 | $2.20M | 0.00% | +4,943+3.9% | Added |
| Ghost Tree Capital, LLC | 120,000 | $2.02M | 1.00% | −50,000−29.4% | Reduced |
| Northern Trust Corp | 68,732 | $1.16M | 0.00% | −3,049−4.2% | Reduced |
| Charles Schwab Investment Management Inc | 48,583 | $818.0K | 0.00% | +1,402+3.0% | Added |
| SG Americas Securities, LLC | 42,439 | $714.0K | 0.01% | −1,891−4.3% | Reduced |
| DLD Asset Management, LP | 32,500 | $547.0K | 0.04% | +32,500 | New |
| Dimensional Fund Advisors LP | 28,855 | $485.0K | 0.00% | +19,865+221.0% | Added |
| Goldman Sachs Group Inc | 28,256 | $475.0K | 0.00% | +153+0.5% | Added |
| Invesco Ltd. | 27,982 | $471.0K | 0.00% | +4,078+17.1% | Added |
| Bank of New York Mellon Corp | 25,111 | $423.0K | 0.00% | −175−0.7% | Reduced |
| Citadel Advisors LLC | 25,101 | $422.0K | 0.00% | +25,101 | New |
| Nuveen Asset Management, LLC | 21,763 | $381.0K | 0.00% | 00.0% | Unchanged |
| Allspring Global Investments Holdings, LLC | 12,760 | $214.0K | 0.00% | −125−1.0% | Reduced |
| Morgan Stanley | 11,211 | $188.0K | 0.00% | −27−0.2% | Reduced |
| J. Goldman & Co LP | 10,544 | $177.0K | 0.01% | +10,544 | New |
| Bank of America Corp | 6,499 | $109.0K | 0.00% | −4,163−39.0% | Reduced |
| Tower Research Capital LLC (TRC) | 6,424 | $108.0K | 0.00% | +5,772+885.3% | Added |
| New York State Common Retirement Fund | 5,881 | $99.0K | 0.00% | +9+0.2% | Added |
| Wells Fargo & Company | 4,713 | $79.0K | 0.00% | −2,941−38.4% | Reduced |
| Deutsche Bank AG | 4,726 | $79.0K | 0.00% | −961−16.9% | Reduced |
| UBS Group AG | 4,226 | $71.0K | 0.00% | +1,142+37.0% | Added |
| American International Group, Inc. | 4,186 | $70.0K | 0.00% | −294−6.6% | Reduced |
| JPMorgan Chase & Co | 3,954 | $67.0K | 0.00% | −170,782−97.7% | Reduced |
| California State Teachers Retirement System | 3,615 | $61.0K | 0.00% | −1,025−22.1% | Reduced |
| Barclays PLC | 2,593 | $44.0K | 0.00% | +2,593 | New |
| STRS Ohio | 2,100 | $35.0K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,306 | $22.0K | 0.00% | +1,306 | New |
| Amalgamated Financial Corp. | 1,306 | $22.0K | 0.00% | +1,306 | New |
| Legal & General Group Plc | 868 | $15.0K | 0.00% | +50+6.1% | Added |
| Royal Bank of Canada | 737 | $13.0K | 0.00% | −1,410−65.7% | Reduced |
| Ameritas Investment Partners, Inc. | 515 | $9.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 316 | $5.00K | 0.00% | −1,829−85.3% | Reduced |
| Advisor Group Holdings, Inc. | 200 | $3.00K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 100 | $2.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 44 | $1.00K | 0.00% | +44 | New |
| American Portfolios Advisors | 39 | $656 | 0.00% | 00.0% | Unchanged |
| Tucker Asset Management LLC | 4 | $67 | 0.00% | 00.0% | Unchanged |
| Frazier Management LLC | 0 | $0 | 0.00% | −1,417,157−100.0% | Sold out |